Drug intelligence / Profile preview

soybean oil (Assistance Publique-Hôpitaux de Marseille)

Development stage
Approved
Lead developer
B. Braun
Modality
Small Molecules
Administration
Intravenous
01

Overview

Endolipide is an intravenous lipid emulsion, typically containing 20% soybean oil, used primarily as a source of energy and essential fatty acids in parenteral nutrition. In the context of clinical research, specifically a Phase 3 academic study conducted by Assistance Publique - Hôpitaux de Marseille (NCT01083472), Endolipide is utilized as a standardized lipid challenge to investigate metabolic regulation. The study evaluates the acute effects of intensive insulin therapy on the production and metabolism of intestinal triglyceride-rich lipoproteins (TRLs) in adults with type 2 diabetes mellitus. By administering Endolipide, researchers can maintain stable plasma lipid levels (a "lipid clamp") to observe how insulin modulates the assembly and secretion of chylomicrons and other lipoproteins, providing insights into the pathophysiology of diabetic dyslipidemia.

Brand names
EndolipideIntralipidLipofundin
Other names
Endolipide 20%lipid emulsionsoybean oil emulsionfat emulsion
02

Targets

LPL (Lipoprotein lipase)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on soybean oil (Assistance Publique-Hôpitaux de Marseille).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soybean oil (Assistance Publique-Hôpitaux de Marseille).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call